![]() |
인쇄하기
취소
|
While JW Joongwae and companies with private equity fund investment have entered acquisition competition of DreamPharma which is a subsidiary of Hanwha Group, it is now focused on what is the merit of acquiring DreamPharma. It is analyzed that the merit of DreamPharma is business power on obesity treatment and research and development division.
First of all, DreamPharma signed contract with Ro...